Ganciclovir

Pharm Company: * RANBAXY
Category: Antiviral

Ganciclovir, sold under the brand name Cytovene among others, is an antiviral medication used to treat cytomegalovirus (CMV) infections. Ganciclovir was patented in 1980 and approved for medical use in 1988.[1] Contents 1 Medical use 2 Adverse effects 2.1 Toxicity 3 Mechanism of action 4 Pharmacokinetics 4.1 Administration 5 See also 6 References 7 Further reading 8 External links Medical use Ganciclovir is indicated for:[2] Sight-threatening CMV ... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Cytovene 500 mg/10ml Intravenous Injection, Powder, Lyophilized, for Solution

NDC: 0004-6940

Labeler:

Genentech, Inc.

Ganciclovir 50 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution

NDC: 0143-9299

Labeler:

Hikma Pharmaceuticals USA Inc.

Ganciclovir 50 mg/ml Intraventricular Injection, Powder, Lyophilized, for Solution

NDC: 14335-030

Labeler:

Hainan Poly Pharm. Co., Ltd.

Ganciclovir 50 mg/ml Intravenous Injection, Solution

NDC: 25021-185

Labeler:

Sagent Pharmaceuticals

Ganciclovir 500 mg/10ml Intravenous Injection, Powder, Lyophilized, for Solution

NDC: 42023-173

Labeler:

Par Pharmaceutical, Inc.

Ganciclovir 2 mg/ml Intravenous Injection, Solution

NDC: 51754-2500

Labeler:

Exela Pharma Sciences, LLC

Ganciclovir 500 mg/10ml Intravenous Injection, Solution

NDC: 51817-171

Labeler:

Pharmascience Inc.

Ganciclovir 50 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution

NDC: 55390-016

Labeler:

Bedford Laboratories

Cytovene 500 mg/10ml Intravenous Injection, Powder, Lyophilized, for Solution

NDC: 61269-450

Labeler:

H2-pharma, LLC

Ganciclovir 250 mg/1 Oral Capsule

NDC: 63304-636

Labeler:

Ranbaxy Pharmaceuticals Inc.

More Results

Related Brands

Drugs with the same active ingredients